Methylsticin
Methylsticin structure
|
Common Name | Methylsticin | ||
|---|---|---|---|---|
| CAS Number | 495-85-2 | Molecular Weight | 274.269 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 496.5±45.0 °C at 760 mmHg | |
| Molecular Formula | C15H14O5 | Melting Point | 139-140.5ºC | |
| MSDS | USA | Flash Point | 223.9±28.8 °C | |
Use of MethylsticinMethylsticin is a kavalactone isolated from the kava roots. Methylsticin exhibit osteoclast formation inhibitory activity[1]. |
| Name | (2R)-2-[(E)-2-(1,3-benzodioxol-5-yl)ethenyl]-4-methoxy-2,3-dihydropyran-6-one |
|---|---|
| Synonym | More Synonyms |
| Description | Methylsticin is a kavalactone isolated from the kava roots. Methylsticin exhibit osteoclast formation inhibitory activity[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Shoujun Chen, et al. Methods of inhibiting osteoclast activity. US20030229137A1. |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 496.5±45.0 °C at 760 mmHg |
| Melting Point | 139-140.5ºC |
| Molecular Formula | C15H14O5 |
| Molecular Weight | 274.269 |
| Flash Point | 223.9±28.8 °C |
| Exact Mass | 274.084137 |
| PSA | 53.99000 |
| LogP | 1.81 |
| Vapour Pressure | 0.0±1.3 mmHg at 25°C |
| Index of Refraction | 1.597 |
| Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| RIDADR | NONH for all modes of transport |
|---|
|
~58%
Methylsticin CAS#:495-85-2 |
| Literature: Soldi, Cristian; Moro, Angelica V.; Pizzolatti, Moacir G.; Correia, Carlos R. D. European Journal of Organic Chemistry, 2012 , # 19 p. 3607 - 3616 |
|
~42%
Methylsticin CAS#:495-85-2 |
| Literature: Amaral, Patricia A.; Gouault, Nicolas; Roch, Myriam Le; Eifler-Lima, Vera L.; David, Michele Tetrahedron Letters, 2008 , vol. 49, # 47 p. 6607 - 6609 |
|
~%
Methylsticin CAS#:495-85-2 |
| Literature: Soldi, Cristian; Moro, Angelica V.; Pizzolatti, Moacir G.; Correia, Carlos R. D. European Journal of Organic Chemistry, 2012 , # 19 p. 3607 - 3616 |
|
~%
Methylsticin CAS#:495-85-2 |
| Literature: Ali Shaik, Ahmad; Tan, Jonathan; Lue, Junxuan; Xing, Chengguo Arkivoc, 2012 , vol. 2012, # 8 p. 137 - 145 |
|
~%
Methylsticin CAS#:495-85-2 |
| Literature: Ali Shaik, Ahmad; Tan, Jonathan; Lue, Junxuan; Xing, Chengguo Arkivoc, 2012 , vol. 2012, # 8 p. 137 - 145 |
|
~%
Methylsticin CAS#:495-85-2 |
| Literature: Klohs et al. Journal of Organic Chemistry, 1959 , vol. 24, p. 1829 |
| Precursor 6 | |
|---|---|
| DownStream 4 | |
CAS#:99-50-3
CAS#:3155-58-6![2-[2-(1,3-benzodioxol-5-yl)ethyl]-4-methoxy-2,3-dihydropyran-6-one structure](https://image.chemsrc.com/caspic/109/3155-57-5.png)
CAS#:3155-57-5|
Fatal kavalactone intoxication by suicidal intravenous injection.
Forensic Sci. Int. 249 , e7-11, (2015) Kavalactones are a group of compounds found in kava, a beverage or extract prepared from the rhizome of the kava plant (Piper methysticum). Traditionally kava extracts have been used for their anxioly... |
|
|
Influence of genuine kavapyrone enantiomers on the GABA-A binding site.
Planta Med. 64(6) , 504-6, (1998) The influence of kavapyrones from Piper methysticum Forst. on the GABAA receptor was demonstrated using radioreceptor assays. Both the dienolide yangonin and the genuine enolide enantiomers (+)-kavain... |
|
|
Interaction of various Piper methysticum cultivars with CNS receptors in vitro.
Planta Med. 67(4) , 306-11, (2001) Methanolic leaf and root extracts of the Hawaiian kava (Piper methysticum Forst.) cultivars, Mahakea, Nene, Purple Moi and PNG, were tested on binding affinities to CNS receptors including GABAA (GABA... |
| 2H-Pyran-2-one, 6-[(E)-2-(1,3-benzodioxol-5-yl)ethenyl]-5,6-dihydro-4-methoxy-, (6S)- |
| (E)-6-[2-(benzo[d][1,3]dioxol-5-yl)vinyl]-4-methoxy-5,6-dihydropyran-2-one |
| 2H-Pyran-2-one, 6-[(E)-2-(1,3-benzodioxol-5-yl)ethenyl]-5,6-dihydro-4-methoxy-, (6R)- |
| (+-)-Methysticin |
| (R-(E))-6-(2-(1,3-Benzodioxol-5-yl)ethenyl)-5,6-dihydro-4-methoxy-2H-pyran-2-one |
| [R-(E)]-6-[2-(1,3-Benzodioxol-5-yl)ethenyl]-5,6-dihydro-4-methoxy-2H-pyran-2-one |
| 6-(3',4'-Methylenedioxystyryl)-4-methoxy-5,6-dihydro-2H-pyran-2-one |
| Kavahin |
| (6S)-6-[(E)-2-(1,3-Benzodioxol-5-yl)vinyl]-4-methoxy-5,6-dihydro-2H-pyran-2-one |
| Methysticin |
| 4-Methoxy-6-[b-(3',4'-methylenedioxyphenyl)vinyl]-5,6-dihydro-a-pyrone |
| (6R)-6-[(E)-2-(1,3-benzodioxol-5-yl)ethenyl]-4-methoxy-5,6-dihydro-2H-pyran-2-one |
| 5-Hydroxy-3-methoxy-7-[3,4-(methylenedioxy)phenyl]-2,6-heptadienoic Acid d-Lactone |
| 6-(2-benzo[1,3]dioxol-5-yl-vinyl)-4-methoxy-5,6-dihydro-pyran-2-one |
| (E)-6-[2-(benzo[d][1,3]dioxol-5-yl)vinyl]-4-methoxy-5,6-dihydro-2H-pyran-2-one |
| (R)-5,6-Dihydro-4-methoxy-6-(3,4-(methylenedioxy)styryl)-2H-pyran-2-one |
| (6R)-6-[(E)-2-(1,3-Benzodioxol-5-yl)vinyl]-4-methoxy-5,6-dihydro-2H-pyran-2-one |
| Kavatin |